Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges

Acta Pharmaceutica Sinica B

Volumn 6, Issue 4, 2016, Pages 287-296

  Ha, Dinh ^a   Yang, Ningning ^a,b   Nadithe, Venkatareddy ^a  

^a MANCHESTER UNIVERSITY   (United States)

^b LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

Drug delivery systems; Exosomes; Extracellular vesicles; Nanocarrier

Indexed keywords

CURCUMIN; DOXORUBICIN; DRUG CARRIER; LET 7A; LIPOSOME; MICRORNA; NANOPARTICLE; NUCLEIC ACID; PACLITAXEL; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

CELL VACUOLE; CHEMICAL COMPOSITION; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; EXOSOME; HUMAN; IMMUNOGENICITY; INTRACELLULAR MEMBRANE; NONHUMAN; REVIEW;

EID: 85006202925     PISSN: 22113835     EISSN: 22113843     Source Type: Journal    
DOI: 10.1016/j.apsb.2016.02.001     Document Type: Review

References (84)

1. 1 Lai, R.C., Yeo, R.W.Y., Tan, K.H., Lim, S.K., Exosomes for drug delivery—a novel application for the mesenchymal stem cell. Biotechnol Adv 31 (2013), 543–551.
2. 2 Kooijmans, S.A., Vader, P., van Dommelen, S.M., van Solinge, W.W., Schiffelers, R.M., Exosome mimetics: a novel class of drug delivery systems. Int J Nanomed 7 (2012), 1525–1541.
3. 3 Schiller, M., Bekeredjian-Ding, I., Heyder, P., Blank, N., Ho, A.D., Lorenz, H.M., Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ 15 (2008), 183–191.
4. 4 Gregory, C.D., Pound, J.D., Microenvironmental influences of apoptosis in vivo and in vitro. Apoptosis 15 (2010), 1029–1049.
5. 5 Johnstone, R.M., Revisiting the road to the discovery of exosomes. Blood Cells Mol Dis 34 (2005), 214–219.
6. 6 Simons, M., Raposo, G., Exosomes-vesicular carriers for intercellular communication. Curr Opin Cell Biol 21 (2009), 575–581.
7. 7 Qin, J., Xu, Q., Functions and applications of exosomes. Acta Pol Pharm 71 (2014), 537–543.
8. 8 Urbanelli, L., Magini, A., Buratta, S., Brozzi, A., Sagini, K., Polchi, A., et al. Signaling pathways in exosomes biogenesis, secretion and fate. Genes 4 (2013), 152–170.
9. 9 Katzmann, D.J., Odorizzi, G., Emr, S.D., Receptor downregulation and multivesicular-body sorting. Nat Rev Mol Cell Biol 3 (2002), 893–905.
10. 10 Février, B., Raposo, G., Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 16 (2004), 415–421.
11. 11 Raiborg, C., Rusten, T.E., Stenmark, H., Protein sorting into multivesicular endosomes. Curr Opin Cell Biol 15 (2003), 446–455.
12. 12 Colombo, M., Moita, C., van Niel, G., Kowal, J., Vigneron, J., Benaroch, P., et al. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci 126 (2013), 5553–5565.
13. 13 Tamai, K., Tanaka, N., Nakano, T., Kakazu, E., Kondo, Y., Inoue, J., et al. Exosome secretion of dendritic cells is regulated by Hrs, an ESCRT-0 protein. Biochem Biophys Res Commun 399 (2010), 384–390.
14. 14 Gross, J.C., Chaudhary, V., Bartscherer, K., Boutros, M., Active Wnt proteins are secreted on exosomes. Nat Cell Biol 14 (2012), 1036–1045.
15. 15 Hoshino, D., Kirkbride, K.C., Costello, K., Clark, E.S., Sinha, S., Grega-Larson, N., et al. Exosome secretion is enhanced by invadopodia and drives invasive behavior. Cell Rep 5 (2013), 1159–1168.
16. 16 Abrami, L., Brandi, L., Moayeri, M., Brown, M.J., Krantz, B.A., Leppla, S.H., et al. Hijacking multivesicular bodies enables long-term and exosome-mediated long-distance action of anthrax toxin. Cell Rep 5 (2013), 986–996.
17. 17 Kowal, J., Tkach, M., Théry, C., Biogenesis and secretion of exosomes. Curr Opin Cell Biol 29 (2014), 116–125.
18. 18 Heijnen, H.F.G., Schiel, A.E., Fijnheer, R., Geuze, H.J., Sixma, J.J., Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and α-granules. Blood 94 (1999), 3791–3799.
19. 19 van Niel, G., Charrin, S., Simoes, S., Romao, M., Rochin, L., Saftig, P., et al. The tetraspanin CD63 regulates ESCRT-independent and-dependent endosomal sorting during melanogenesis. Dev Cell 21 (2011), 708–721.
20. 20 Denzer, K., Kleijmeer, M.J., Heijnen, H., Stoorvogel, W., Geuze, H.J., Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 113 (2000), 3365–3374.
21. 21 Lamparski, H.G., Metha-Damani, A., Yao, J.-Y., Patel, S., Hsu, D.-H., Ruegg, C., et al. Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods 270 (2002), 211–226.
22. 22 Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes. Nat Med 4 (1998), 594–600.
23. 23 Simpson, R.J., Mathivanan, S., Extracellular microvesicles: the need for internationally recognised nomenclature and stringent purification criteria. J Proteom Bioinform, 5, 2012, 2.
24. 24 Vlassov, A.V., Magdaleno, S., Setterquist, R., Conrad, R., Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 1820 (2012), 940–948.
25. 25 Batrakova, E.V., Kim, M.S., Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release 219 (2015), 396–405.
26. + T cells by dendritic cell-derived exosomes. Nat Immunol 3 (2002), 1156–1162.
27. 27 Kalani, A., Tyagi, A., Tyagi, N., Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics. Mol Neurobiol 49 (2014), 590–600.
28. 28 Subra, C., Laulagnier, K., Perret, B., Record, M., Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. Biochimie 89 (2007), 205–212.
29. 29 Parolini, I., Federici, C., Raggi, C., Lugini, L., Palleschi, S., De Milito, A., et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem 284 (2009), 34211–34222.
30. 30 Piccin, A., Murphy, W.G., Smith, O.P., Circulating microparticles: pathophysiology and clinical implications. Blood Rev 21 (2007), 157–171.
31. 31 Johnstone, R.M., Adam, M., Hammond, J., Orr, L., Turbide, C., Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 262 (1987), 9412–9420.
32. 32 Johnstone, R.M., Mathew, A., Mason, A.B., Teng, K., Exosome formation during maturation of mammalianand avian reticulocytes: evidence that exosome release is a major route for externalization of obsolete membrane proteins. J Cell Physiol 147 (1991), 27–36.
33. 33 Morelli, A.E., Larregina, A.T., Shufesky, W.J., Sullivan, M.L.G., Stolz, D.B., Papworth, G.D., et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 104 (2004), 3257–3266.
34. 34 De Toro, J., Herschlik, L., Waldner, C., Mongini, C., Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front Immunol, 6, 2015, 203.
35. 35 Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J.J., Lötvall, J.O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9 (2007), 654–659.
36. 36 Skog, J., Würdinger, T., van Rijn, S., Meijer, D.H., Gainche, L., Curry, W.T., et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10 (2008), 1470–1476.
37. 37 Laulagnier, K., Grand, D., Dujardin, A., Hamdi, S., Vincent-Schneider, H., Lankar, D., et al. PLD2 is enriched on exosomes and its activity is correlated to the release of exosomes. FEBS Lett 572 (2004), 11–14.
38. 38 Aharon, A., Microparticles, Brenner B., thrombosis and cancer. Best Pract Res Clin Haematol 22 (2009), 61–69.
39. 39 Kucharzewska, P., Christianson, H.C., Welch, J.E., Svensson, K.J., Fredlund, E., Ringnér, M., et al. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc Natl Acad Sci U S A 110 (2013), 7312–7317.
40. 40 Webber, J., Steadman, R., Mason, M.D., Tabi, Z., Clayton, A., Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res 70 (2010), 9621–9630.
41. 41 Rana, S., Malinowska, K., Zöller, M., Exosomal tumor microRNA modulates premetastatic organ cells. Neoplasia 15 (2013), 281–295.
42. 42 Ghidoni, R., Benussi, L., Binetti, G., Exosomes: the Trojan horses of neurodegeneration. Med Hypotheses 70 (2008), 1226–1227.
43. 43 Nilsson, J., Skog, J., Nordstrand, A., Baranov, V., Mincheva-Nilsson, L., Breakefield, X.O., et al. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer 100 (2009), 1603–1607.
44. 44 Corcoran, C., Friel, A.M., Duffy, M.J., Crown, J., O׳Driscoll, L., Intracellular and extracellular microRNAs in breast cancer. Clin Chem 57 (2011), 18–32.
45. 45 Li, J.H., Sherman-Baust, C.A., Tsai-Turton, M., Bristow, R.E., Roden, R.B., Morin, P.J., Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer. BMC Cancer, 9, 2009, 244.
46. 46 Sercombe, L., Veerati, T., Moheimani, F., Wu, S.Y., Sood, A.K., Hua, S., Advances and challenges of liposome assisted drug delivery. Front Pharmacol, 6, 2015, 286.
47. 47 Agrawal, U., Sharma, R., Gupta, M., Vyas, S.P., Is nanotechnology a boon for oral drug delivery?. Drug Discov Today 19 (2014), 1530–1546.
48. 48 Raemdonck, K., Braeckmans, K., Demeester, J., De Smedt, S.C., Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery. Chem Soc Rev 43 (2014), 444–472.
49. 49 Li, C., Zhang, J., Zu, Y.J., Nie, S.F., Cao, J., Wang, Q., et al. Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals. Chin J Nat Med 13 (2015), 641–652.
50. 50 Aryani, A., Denecke, B., Exosomes as a nanodelivery system: a key to the future of neuromedicine?. Mol Neurobiol 53 (2016), 818–834.
51. 51 Turturici, G., Tinnirello, R., Sconzo, G., Geraci, F., Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages. Am J Physiol Cell Physiol 306 (2014), C621–C633.
52. 52 Rani, S., Ritter, T., The exosome-a naturally secreted nanoparticle and its application to wound healing. Adv Mater, 2015 Dec 17. Available from: 10.1002/adma.201504009.
53. 53 Sun, D.M., Zhuang, X.Y., Xiang, X.Y., Liu, Y.L., Zhang, S.Y., Liu, C.R., et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther 18 (2010), 1606–1614.
54. 54 Tian, Y.H., Li, S.P., Song, J., Ji, T.J., Zhu, M.T., Anderson, G.J., et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 35 (2014), 2383–2390.
55. 55 Yang, T.Z., Martin, P., Fogarty, B., Brown, A., Schurman, K., Phipps, R., et al. Exosome delivered anticancer drugs across the blood–brain barrier for brain cancer therapy in Danio Rerio. Pharm Res 32 (2015), 2003–2014.
56. 56 Haney, M.J., Klyachko, N.L., Zhao, Y.L., Gupta, R., Plotnikova, E.G., He, Z.J., et al. Exosomes as drug delivery vehicles for Parkinson׳s disease therapy. J Control Release 207 (2015), 18–30.
57. 57 Wahlgren, J., Karlson, T.D.L., Brisslert, M., Sani, F.V., Telemo, E., Sunnerhagen, P., et al. Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes. Nucleic Acids Res, 40, 2012, e130.
58. 58 Shtam, T.A., Kovalev, R.A., Varfolomeeva, E.Y., Makarov, E.M., Kil, Y.V., Filatov, M.V., Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Commun Signal 11 (2013), 1186–1196.
59. 59 Banizs, A.B., Huang, T., Dryden, K., Berr, S.S., Stone, J.R., Nakamoto, R.K., et al. In vitro evaluation of endothelial exosomes as carriers for small interfering ribonucleic acid delivery. Int J Nanomed 9 (2014), 4223–4230.
60. 60 Ohno, S., Takanashi, M., Sudo, K., Ueda, S., Ishikawa, A., Matsuyama, N., et al. Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells. Mol Ther 21 (2013), 185–191.
61. 61 Ravindran, J., Prasad, S., Aggarwal, B.B., Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?. AAPS J 11 (2009), 495–510.
62. 62 Aggarwal, B.B., Harikumar, K.B., Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 41 (2009), 40–59.
63. 63 Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A.B., Aggarwal, B.B., Curcumin and cancer: an “old-age” disease with an “age-old” solution. Cancer Lett 267 (2008), 133–164.
64. 64 Dhillon, N., Aggarwal, B.B., Newman, R.A., Wolff, R.A., Kunnumakkara, A.B., Abbruzzese, J.L., et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14 (2008), 4491–4499.
65. 65 Anand, P., Kunnumakkara, A.B., Newman, R.A., Aggarwal, B.B., Bioavailability of curcumin: problemsand promises. Mol Pharm 4 (2007), 807–818.
66. 66 Pardridge, W.M., Drug transport across the blood–brain barrier. J Cereb Blood Flow Metab 32 (2012), 1959–1972.
67. 67 Peng, Q., Zhang, S., Yang, Q., Zhang, T., Wei, X.Q., Jiang, L., et al. Preformed albumin corona, a protective coating for nanoparticles based drug delivery system. Biomaterials 34 (2013), 8521–8530.
68. 68 Yoshida, K., Burton, G.F., McKinney, J.S., Young, H., Ellis, E.F., Brain and tissue distribution of polyethylene glycol-conjugated superoxide dismutase in rats. Stroke 23 (1992), 865–869.
69. 69 Veronese, F.M., Caliceti, P., Schiavon, O., Sergi, M., Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation. Adv Drug Deliv Rev 54 (2002), 587–606.
70. 70 Ebadi, M., Srinivasan, S.K., Baxi, M.D., Oxidative stress and antioxidant therapy in Parkinson׳s disease. Prog Neurobiol 48 (1996), 1–19.
71. 71 Wu, D.C., Teismann, P., Tieu, K., Vila, M., Jackson-Lewis, V., Ischiropoulos, H., et al. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson׳s disease. Proc Natl Acad Sci USA 100 (2003), 6145–6150.
72. 72 Ambani, L.M., Van Woert, M.H., Murphy, S., Brain peroxidase and catalase in Parkinson disease. Arch Neurol 32 (1975), 114–118.
73. 73 Riederer, P., Sofic, E., Rausch, W.D., Schmidt, B., Reynolds, G.P., Jellinger, K., et al. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52 (1989), 515–520.
74. 74 Abraham, S., Soundararajan, C.C., Vivekanandhan, S., Behari, M., Erythrocyte antioxidant enzymes in Parkinson's disease. Indian J Med Res 121 (2005), 111–115.
75. 75 Alvarez-Erviti, L., Seow, Y., Yin, H.F., Betts, C., Lakhal, S., Wood, M.J.A., Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29 (2011), 341–345.
76. 76 Shtam, T.A., Varfolomeeva, E.Y., Semenova, E.V., Filatov, M.V., Role of human RAD51 recombinase in the cycle checkpoint and survival of a cell. Cell Tissue Biol 2 (2008), 463–467.
77. 77 Bartel, D.P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004), 281–297.
78. 78 Bartel, D.P., MicroRNAs: target recognition and regulatory functions. Cell 136 (2009), 215–233.
79. 79 Woodburn, J.R., The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacol Ther 82 (1999), 241–250.
80. 80 Mehrotra, N., Tripathi, R.M., Short interfering RNA therapeutics: nanocarriers, prospects and limitations. IET Nanobiotechnol 9 (2015), 386–395.
81. 81 Tran, T.-H., Mattheolabakis, G., Aldawsari, H., Amiji, M., Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases. Clin Immunol 160 (2015), 46–58.
82. 82 Petersen, K.E., Manangon, E., Hood, J.L., Wickline, S.A., Fernandez, D.P., Johnson, W.P., et al. A review of exosome separation techniques and characterization of B16-F10 mouse melanoma exosomes with AF4-UV-MALS-DLS-TEM. Anal Bioanal Chem 406 (2014), 7855–7866.
83. 83 Taylor, D.D., Shah, S., Methods of isolating extracellular vesicles impact down-stream analyses of their cargoes. Methods 87 (2015), 3–10.
84. 84 Rana, S., Yue, S.J., Stadel, D., Zöller, M., Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. Int J Biochem Cell Biol 44 (2012), 1574–1584.